References:
  1. Berenholz L, Katzenell U, Harell M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope . 2002;112(9):1619‐1622. doi:10.1097/00005537-200209000-00017
  2. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope . 2007;117(5):907‐910. doi:10.1097/MLG.0b013e318039b30f
  3. Peled C, El-Seid S, Bahat-Dinur A, et al. Necrotizing Otitis Externa-Analysis of 83 Cases: Clinical Findings and Course of Disease. OtolNeurotol . 2019;40(1):56‐62. doi:10.1097/MAO.0000000000001986
  4. Mahdyoun P, Pulcini C, Gahide I, et al. Necrotizing otitis externa: a systematic review. OtolNeurotol . 2013;34(4):620‐629. doi:10.1097/MAO.0b013e3182804aee
  5. Hollis S, Evans K. Management of malignant (necrotising) otitis externa. J Laryngol Otol . 2011;125(12):1212‐1217. doi:10.1017/S0022215110002550
  6. Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI. Predicting outcome of malignant external otitis. OtolNeurotol . 2008;29(3):339‐343. doi:10.1097/MAO.0b013e3181661879
  7. Loh S, Loh WS. Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg . 2013;148(6):991‐996. doi:10.1177/0194599813482107
  8. Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V. Necrotizing external otitis: a report of 46 cases. OtolNeurotol . 2007;28(6):771‐773. doi:10.1097/MAO.0b013e31805153bd
  9. Cohen D, Friedman P. The diagnostic criteria of malignant external otitis. J Laryngol Otol . 1987;101(3):216‐221. doi:10.1017/s0022215100101562
  10. American Diabetes Association. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019Diabetes Care . 2019;42(Suppl 1):S173‐S181. doi:10.2337/dc19-S015
  11. Peled C, Kraus M, Kaplan D. Diagnosis and treatment of necrotising otitis externa and diabetic foot osteomyelitis - similarities and differences. J Laryngol Otol . 2018;132(9):775‐779. doi:10.1017/S002221511800138X
  12. Stern Shavit S, Soudry E, Hamzany Y, Nageris B. Malignant external otitis: Factors predicting patient outcomes. Am J Otolaryngol . 2016;37(5):425‐430. doi:10.1016/j.amjoto.2016.04.005
  13. Lee SK, Lee SA, Seon SW, et al. Analysis of Prognostic Factors in Malignant External Otitis. ClinExpOtorhinolaryngol . 2017;10(3):228‐235. doi:10.21053/ceo.2016.00612
  14. Carfrae MJ, Kesser BW. Malignant otitis externa. OtolaryngolClin North Am . 2008;41(3):537‐ix. doi:10.1016/j.otc.2008.01.004
  15. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant external otitis: survival vs mortality. ActaOtolaryngol . 2010;130(1):89‐94. doi:10.3109/00016480902971247
  16. Naghibi M, Smith RP, Baltch AL, et al. The effect of diabetes mellitus on chemotactic and bactericidal activity of human polymorphonuclear leukocytes. Diabetes Res ClinPract . 1987;4(1):27‐35. doi:10.1016/s0168-8227(87)80030-x
  17. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol . 1999;26(3-4):259‐265. doi:10.1111/j.1574-695X.1999.tb01397.x